NASDAQ:ACXP

Acurx Pharmaceuticals Stock Predictions

etoro logo Buy ACXP
*Your capital is at risk
$1.75
-0.0500 (-2.78%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ACXP Prediction Chart

ACXP Predictions History

Latest community submissions for ACXP.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 13, 2025 $7.22 -3.52% $7.16 V 99.20% 3
Oct 13, 2025 $7.32 -2.20% $7.16 V 97.83% 1
Oct 13, 2025 Bullish $7.16 X 0
Jun 20, 2025 $0.699 -2.92% $0.550 V 72.92% 1
Jun 20, 2025 $0.790 +9.72% $0.550 X 56.36% 0
Feb 24, 2025 $0.758 -3.10% $0.85 X 89.45% 0
Feb 24, 2025 $0.767 -1.94% $0.85 X 90.52% 0
Feb 24, 2025 $0.783 +0.00% $0.85 X 92.31% 0
Feb 24, 2025 Bullish $0.85 V 1
JS JS Pro
Jan 30, 2024 $3.58 -2.72% $3.55 V 99.15% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACXP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ACURX PHARMACEUTICALS, INC.
Acurx Pharmaceuticals
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bac...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE